Screening pathways and hub genes involved in osteoclastogenesis by gene expression analysis of circulating monocytes based on Gibbs sampling

Xiao,Yu; Zhao,Xue-Ping

doi:10.3892/etm.2019.7225

Screening pathways and hub genes involved in osteoclastogenesis by gene expression analysis of circulating monocytes based on Gibbs sampling

Authors:
- Yu Xiao
- Xue-Ping Zhao
View Affiliations

Affiliations: Department of Joint, Tianjin Hospital, Hexi, Tianjin 300211, P.R. China, Department of Orthopedics, Guizhou Space Hospital, Zunyi, Guizhou 563000, P.R. China
Published online on: January 31, 2019 https://doi.org/10.3892/etm.2019.7225
Pages: 2529-2534
Copyright: © Xiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Differential expression pathways and hub genes in circulating monocytes from healthy Chinese women with high peak bone mass (PBM) vs. low PBM were explored using a Markov chain Monte Carlo (MCMC) algorithm. Human circulating monocytes transcription profiling (containing 14 samples with high PBM and 12 samples with low PBM) and KEGG pathways were all downloaded from the public database. Initial state of all the pathways were constructed and Gibbs sampling was performed to obtain a Markov chain and the posterior values of all the pathways were calculated. The probability (α) of occurrence of each pathway was calculated based on the posterior value and it was adjusted by taking gene expression variation into account. Pathways with αadj >0.8 were considered as differentially expressed pathways. Then, these steps were performed again on all the genes in the differentially expressed pathways to find the hub genes in the differential pathways. After Gibbs sampling, neuroactive ligand-receptor interaction (hsa04080) with αadj = 0.986 was screened out as the differentially expressed pathway. Analyzing the genes in this pathway, three genes (neurotensin, tachykinin receptor 3 and follicle-stimulating hormone receptor) with αadj >0.8 were identified as hub genes in circulating monocytes which may associate with osteoporosis development. One pathway and three genes which may possess close relationship with osteoporosis development were found in this study. These results provide insights into our understanding of the role of circulating monocytes in osteoporosis development.

View Figures

View References

1	Lei SF, Wu S, Li LM, Deng FY, Xiao SM, Jiang C, Chen Y, Jiang H, Yang F, Tan LJ, et al: An in vivo genome wide gene expression study of circulating monocytes suggested GBP1, STAT1 and CXCL10 as novel risk genes for the differentiation of peak bone mass. Bone. 44:1010–1014. 2009. View Article : Google Scholar : PubMed/NCBI
2	Cooper C, Westlake S, Harvey N, Javaid K, Dennison E and Hanson M: Developmental origins of osteoporotic fracture (Review). Osteoporos Int. 17:337–347. 2006. View Article : Google Scholar : PubMed/NCBI
3	Lu J, Shin Y, Yen MS and Sun SS: Peak bone mass and patterns of change in total bone mineral density and bone mineral contents from childhood into young adulthood. J Clin Densitom. 19:180–191. 2016. View Article : Google Scholar : PubMed/NCBI
4	Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V and Weaver C: Peak bone mass. Osteoporos Int. 11:985–1009. 2000. View Article : Google Scholar : PubMed/NCBI
5	Zhou Y, Deng HW and Shen H: Circulating monocytes: An appropriate model for bone-related study. Osteoporos Int. 26:2561–2572. 2015. View Article : Google Scholar : PubMed/NCBI
6	Jiménez-Ortega RF, Ramírez-Salazar EG, Parra-Torres AY, Muñoz-Montero SA, Rangel-Escareňo C, Salido-Guadarrama I, Rodriguez-Dorantes M, Quiterio M, Salmerón J and Velázquez-Cruz R: Identification of microRNAs in human circulating monocytes of postmenopausal osteoporotic Mexican Mestizo women: A pilot study. Exp Ther Med. 14:5464–5472. 2017.PubMed/NCBI
7	Deng FY, Liu YZ, Li LM, Jiang C, Wu S, Chen Y, Jiang H, Yang F, Xiong JX, Xiao P, et al: Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density. Proteomics. 8:4259–4272. 2008. View Article : Google Scholar : PubMed/NCBI
8	Walsh B: Markov Chain Monte Carlo and Gibbs Sampling. http://staff.ustc.edu.cn/~jbs/mcmc-gibbs-intro.pdfMarch 5–2017
9	Bolstad BM, Irizarry RA, Astrand M and Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
10	Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
11	Kanehisa M and Goto S: KEGG: Kyoto encyclopaedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar : PubMed/NCBI
12	Chen P, Guo LH, Guo YK, Qu ZJ, Gao Y and Qiu H: Identification of disturbed pathways in heart failure based on Gibbs sampling and pathway enrichment analysis. Genet Mol Res. 15:2016.https://doi.org/10.4238/gmr.15027956.
13	Chen J, Wang L, Shen Y, Yu J, Ye T, Zhuang C and Zhang W: Key genes associated with osteoporosis revealed by genome wide gene expression analysis. Mol Biol Rep. 41:5971–5977. 2014. View Article : Google Scholar : PubMed/NCBI
14	Carraway R and Leeman SE: The amino acid sequence of a hypothalamic peptide, neurotensin. J Biol Chem. 250:1907–1911. 1975.PubMed/NCBI
15	Patel AB, Tsilioni I, Leeman SE and Theoharides TC: Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism. Proc Natl Acad Sci USA. E7049–E7058. 2016. View Article : Google Scholar : PubMed/NCBI
16	Law IK, Bakirtzi K, Polytarchou C, Oikonomopoulos A, Hommes D, Iliopoulos D and Pothoulakis C: Neurotensin - regulated miR-133α is involved in proinflammatory signalling in human colonic epithelial cells and in experimental colitis. Gut. 64:1095–1104. 2015. View Article : Google Scholar : PubMed/NCBI
17	Mustain WC, Rychahou PG and Evers BM: The role of neurotensin in physiologic and pathologic processes. Curr Opin Endocrinol Diabetes Obes. 18:75–82. 2011. View Article : Google Scholar : PubMed/NCBI
18	Boules MM, Fredrickson P, Muehlmann AM and Richelson E: Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. Behav Sci (Basel). 4:125–153. 2014. View Article : Google Scholar : PubMed/NCBI
19	Obata K, Shimo T, Okui T, Matsumoto K, Takada H, Takabatake K, Kunisada Y, Ibaragi S, Nagatsuka H and Sasaki A: Tachykinin receptor 3 distribution in human oral squamous cell carcinoma. Anticancer Res. 36:6335–6341. 2016. View Article : Google Scholar : PubMed/NCBI
20	Karpouzis A, Avgeridis P, Tripsianis G, Gatzidou E, Kourmouli N and Veletza S: Assessment of tachykinin receptor 3′ gene polymorphism rs3733631 in Rosacea. Int Sch Res Notices. 2015:4694022015.PubMed/NCBI
21	Allan CM, Kalak R, Dunstan CR, McTavish KJ, Zhou H, Handelsman DJ and Seibel MJ: Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci USA. 107:22629–22634. 2010. View Article : Google Scholar : PubMed/NCBI
22	Wang J, Zhang W, Yu C, Zhang X, Zhang H, Guan Q, Zhao J and Xu J: Follicle-stimulating hormone increases the risk of postmenopausal osteoporosis by stimulating osteoclast differentiation. PLoS One. 10:e01349862015. View Article : Google Scholar : PubMed/NCBI
23	Feng Y, Zhu S, Antaris AL, Chen H, Xiao Y, Lu X, Jiang L, Diao S, Yu K, Wang Y, et al: Live imaging of follicle stimulating hormone receptors in gonads and bones using near infrared II fluorophore. Chem Sci (Camb). 8:3703–3711. 2017. View Article : Google Scholar
24	Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, et al: FSH directly regulates bone mass. Cell. 125:247–260. 2006. View Article : Google Scholar : PubMed/NCBI